Scientists test new PET tracer to see prostate cancer up close
NCT ID NCT03334500
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This early-phase study tests a new radioactive tracer called 18F-FluorThanatrace to see how well it can detect PARP-1 activity in prostate cancer tumors. About 30 men with prostate cancer who are scheduled for surgery will get a PET/CT scan with this tracer. The scan results will be compared with tissue samples to learn more about the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.